| NCT Number | NCT07215039 |
| Lead Sponsor | Mayo Clinic |
| Conditions | Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm |
| Enrollment | 1,200 participants |
| Start Date | 2025-11-10 |
| Primary Completion | 2027-10-30 (estimated) |
| Study Completion | 2027-10-30 (estimated) |
| Updated on ClinicalTrials.gov | 2026-04-17 |